Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

An initiative to develop consensus-based industry standards to identify and define green chemicals and process technologies is underway.

Industry Considers Green-Chemistry Standards

Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more...

Company and People Notes: Forest Labs and AstraZeneca Form Pact; Endo COO Resigns; More...

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Manufacturing methods for new drugs could be made greener and more efficient with the help of marine microbes.

UK Researchers Target Marine Microbes for Green Manufacturing

Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire; more...

Company and People Notes: Nabi and GSK Form Pact; Cardinal Health Names CEO; More...

Baxter International (Deerfield, IL), sanofi aventis (Paris), and Novartis (Basel, Switzerland) provided updates last week of their production and regulatory activities relating to preparedness in supplying the A(H1N1) pandemic influenza vaccine. Novartis also outlined its activities for providing seasonal flu vaccines.

Companies Update Activities for Pandemic and Seasonal Flu Vaccines

The Society of Chemical Manufacturers and Affiliates (SOCMA) reported in late July that Eurostat, the Statistical Office of the European Communities, recently published a baseline study or the first snapshot of REACH policy in the preregistration phase.

EU Issues Study on REACH Implementation

Also, Pfizer forms two research agreements in China; NanoInk appoints John Kubricky to its scientific advisory board; more...

Company and People Notes: Cherokee and DuPont Form Supply Agreement; Mylan Makes Changes in Management Team; More...

Biologics enhance their positions amidst slowing growth in the global and US markets.

Shifting Fortunes in API Market Growth

Brief pharmaceutical news items for August 2009.

Pharma Capsules

Biotech firms must first close the gaps between science and biology on the path toward QbD.

Ingredients